Recent Advances in Drug–Antibody Ratio Determination of Antibody–Drug Conjugates
Authors:
- 1 October 2021
- journal article
- review article
- Published by Pharmaceutical Society of Japan in Chemical and Pharmaceutical Bulletin
- Vol. 69 (10) , 976-983
Abstract
Antibody–drug conjugates (ADCs) are biopharmaceuticals produced by chemically linking small molecules (payloads) to antibodies that possess specific affinity for the target cell. The ADCs currently on the commercially market are the result of a stochastic conjugation of highly-potent payloads to multiple sites on the monoclonal antibody, resulting in a heterogeneous drug–antibody ratio (DAR) and drug distribution. The heterogeneity inherent to ADCs not produced site-specifically may not only be detrimental to the quality of the drug but also is less-desirable from the perspective of regulatory science. An ideal method or unified approach used to measure the DAR for ADCs, a critical aspect of their analysis and characterization, has not yet been established in the ADC field and remains an often-challenging issue for bioanalytical chemists. In this review we describe, compare, and evaluate the characteristics of various DAR determination methods for ADCs featuring recently reported technologies. The future landscape of bioconjugate DAR analysis is also discussed.Keywords
This publication has 75 references indexed in Scilit:
- Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC: overview and applicationsmAbs, 2014
- Purification of monoclonal antibodies by hydrophobic interaction chromatography under no-salt conditionsmAbs, 2013
- Analytical FcRn affinity chromatography for functional characterization of monoclonal antibodiesmAbs, 2013
- Drug-to-Antibody Ratio (DAR) and Drug Load Distribution by Hydrophobic Interaction Chromatography and Reversed Phase High-Performance Liquid Chromatography2013
- Native Intact Mass Determination of Antibodies Conjugated with Monomethyl Auristatin E and F at Interchain Cysteine ResiduesAnalytical Chemistry, 2012
- Analytical methods for physicochemical characterization of antibody drug conjugatesmAbs, 2011
- Charge variants in IgG1mAbs, 2010
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic indexNature Biotechnology, 2008
- Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug ConjugateClinical Cancer Research, 2004
- Tissue sulfhydryl groupsArchives of Biochemistry and Biophysics, 1959